HuGE Literature Finder
Records 1-30
|
A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristics.
Blood cancer journal 2020 Apr 10 (4): 43. Sánchez Ricardo, Ribera Jordi, Morgades Mireia, Ayala Rosa, Onecha Esther, Ruiz-Heredia Yanira, Juárez-Rufián Alexandra, de Nicolás Rodrigo, Sánchez-Pina José, Vives Susana, Zamora Lurdes, Mercadal Santiago, Coll Rosa, Cervera Marta, García Olga, Ribera Josep-Maria, Martínez-López Joaqu |
|
Impact of the variant allele frequency of ASXL1, DNMT3A, JAK2, TET2, TP53, and NPM1 on the outcomes of patients with newly diagnosed acute myeloid leukemia.
Cancer 2019 Nov . Sasaki Koji, Kanagal-Shamanna Rashmi, Montalban-Bravo Guillermo, Assi Rita, Jabbour Elias, Ravandi Farhad, Kadia Tapan, Pierce Sherry, Takahashi Koichi, Nogueras Gonzalez Graciela, Patel Keyur, Soltysiak Kelly A, Cortes Jorge, Kantarjian Hagop, Garcia-Manero Guiller |
|
Myeloid malignancies with isolated 7q deletion can be further characterized by their accompanying molecular mutations.
Genes, chromosomes & cancer 2019 Apr . Hartmann Luise, Haferlach Claudia, Meggendorfer Manja, Kern Wolfgang, Haferlach Torsten, Stengel An |
|
The germline JAK2 GGCC (46/1) haplotype and survival among 414 molecularly-annotated patients with primary myelofibrosis.
American journal of hematology 2019 Mar 94 (3): 299-305. Tefferi Ayalew, Lasho Terra L, Mudireddy Mythri, Finke Christy M, Hanson Curtis A, Ketterling Rhett P, Gangat Naseema, Pardanani Anime |
|
Effects of polymorphic DNA genes involved in BER and caspase pathways on the clinical outcome of myeloproliferative neoplasms under treatment with hydroxyurea.
Molecular medicine reports 2018 Oct . Azevedo Ana P, Silva Susana N, Reichert Alice, Lima Fernando, Júnior Esmeraldina, Rueff Jo |
|
Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors.
Medical oncology (Northwood, London, England) 2018 Aug 35 (9): 119. Helbig Grzego |
|
Genomic and outcome analyses of Ph-like ALL in NCI standard-risk patients: a report from the Children's Oncology Group.
Blood 2018 Jul . Roberts Kathryn G, Reshmi Shalini C, Harvey Richard C, Chen I-Ming, Patel Kinnari, Stonerock Eileen, Jenkins Heather, Dai Yunfeng, Valentine Marc, Gu Zhaohui, Zhao Yaqi, Zhang Jinghui, Payne-Turner Debbie, Devidas Meenakshi, Heerema Nyla A, Carroll Andrew J, Raetz Elizabeth A, Borowitz Michael J, Wood Brent L, Mattano Leonard A, Maloney Kelly W, Carroll William L, Loh Mignon L, Willman Cheryl L, Gastier-Foster Julie M, Mullighan Charles G, Hunger Stephen |
|
Molecular Markers and Prognosis of Myelofibrosis in the Genomic Era: A Meta-analysis.
Clinical lymphoma, myeloma & leukemia 2018 Jun . Lee Yen-Chien, Hsieh Chung-Cheng, Lee Yen-Ling, Li Chung- |
|
ASXL1 mutations in Chinese patients with essential thrombocythemia.
Experimental and therapeutic medicine 2018 May 15 (5): 4149-4156. Nie Yan-Bo, Sun Meng, He Colin K, Ju Man-Kai, Zhou Fu-Ling, Wu San-Yun, Zhou Yi, Liu Li, Shen Hui, Huang Ting-Ting, Liu Pan, Xu Ying, Shao Liang, Zuo Xue-L |
|
Copy number abnormality of acute lymphoblastic leukemia cell lines based on their genetic subtypes.
International journal of hematology 2018 May . Tomoyasu Chihiro, Imamura Toshihiko, Tomii Toshihiro, Yano Mio, Asai Daisuke, Goto Hiroaki, Shimada Akira, Sanada Masashi, Iwamoto Shotaro, Takita Junko, Minegishi Masayoshi, Inukai Takeshi, Sugita Kanji, Hosoi Haji |
|
Clonal interference of signaling mutations holds prognostic relevance in core binding factor acute myeloid leukemia.
Blood 2018 Apr . Itzykson Raphael, Duployez Nicolas, Fasan Annette, Decool Gauthier, Marceau-Renaut Alice, Meggendorfer Manja, Jourdan Eric, Petit Arnaud, Lapillonne Hélène, Micol Jean-Baptiste, Cornillet-Lefebvre Pascale, Ifrah Norbert, Leverger Guy, Dombret Hervé, Boissel Nicolas, Haferlach Torsten, Preudhomme Clau |
|
Chronic Myelomonocytic Leukemia With Fibrosis is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations.
The American journal of surgical pathology 2018 Mar . Deniz Gur, Loghavi Sanam, Garcia-Manero Guillermo, Routbort Mark, Kanagal-Shamanna Rashmi, Quesada Andres, Khogeer Haitham, Pierce Sherry, Medeiros L Jeffrey, Kantarjian Hagop, Khoury Joseph |
|
Prognostic impact of kinase-activating fusions and IKZF1 deletions in pediatric high-risk B-lineage acute lymphoblastic leukemia.
Blood advances 2018 Mar 2 (5): 529-533. Tran Thai Hoa, Harris Marian H, Nguyen Jonathan V, Blonquist Traci M, Stevenson Kristen E, Stonerock Eileen, Asselin Barbara L, Athale Uma H, Clavell Luis A, Cole Peter D, Kelly Kara M, Laverdiere Caroline, Leclerc Jean-Marie, Michon Bruno, Schorin Marshall A, Welch Jennifer J G, Reshmi Shalini C, Neuberg Donna S, Sallan Stephen E, Loh Mignon L, Silverman Lewis |
|
[Spectrum of somatic mutations and their prognostic significance in adult patients with B cell acute lymphoblastic leukemia].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2018 Feb 39 (2): 98-104. Feng J, Gong X Y, Jia Y J, Liu K Q, Li Y, Dong X B, Fang Q Y, Ru K, Li Q H, Wang H J, Zhao X L, Jia Y N, Song Y, Tian Z, Wang M, Tang K J, Wang J X, Mi Y |
|
Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.
Annals of hematology 2018 Jan 97 (1): 109-121. Boddu Prajwal, Masarova Lucia, Verstovsek Srdan, Strati Paolo, Kantarjian Hagop, Cortes Jorge, Estrov Zeev, Pierce Sherry, Pemmaraju Nave |
|
Determination of CEBPA mutations by next generation sequencing in pediatric acute leukemia.
Bratislavske lekarske listy 2018 119 (6): 366-372. Akin D F, Oner D A, Kurekci E, Akar |
|
Effect of CALR and JAK2 mutations on the clinical and hematological phenotypes of the disease in patients with myelofibrosis - long-term experience from a single center.
Neoplasma 2018 65 (2): 296-303. Palova M, Szotkowski T, Hlusi A, Indrak K, Navratilova J, Divoka M, Papajik |
|
Prevalence of MPL (W515K/L) Mutations in Patients with Negative-JAK2 (V617F) Myeloproliferative Neoplasm in North-East of Iran.
Iranian journal of pathology 2018 13 (4): 397-402. Shams Seyyede Fatemeh, Ayatollahi Hossein, Sadeghian Mohammad Hadi, Afzalaghaee Monavar, Shakeri Sepideh, Yazdandoust Ehsan, Sheikhi Maryam, Amini Nafiseh, Bakhshi Samane, Bahrami Afsa |
|
The clinical and prognostic relevance of driver mutations in 203 Taiwanese patients with primary myelofibrosis.
Journal of clinical pathology 2017 Dec . Kuo Ming-Chung, Lin Tung-Huei, Sun Chien-Feng, Lin Tung-Liang, Wu Jin-Hou, Wang Po-Nan, Huang Ying-Jung, Chang Hung, Huang Ting-Yu, Shih Lee-Yu |
|
Bone marrow fibrosis in chronic myelomonocytic leukemia is associated with increased megakaryopoiesis, splenomegaly and with a shorter median time to disease progression.
Oncotarget 2017 Nov 8 (61): 103274-103282. Petrova-Drus Kseniya, Chiu April, Margolskee Elizabeth, Barouk-Fox Sharon, Geyer Julia, Dogan Ahmet, Orazi Attil |
|
Driver mutations and prognosis in primary myelofibrosis: Mayo-Careggi MPN alliance study of 1,095 patients.
American journal of hematology 2017 Nov . Tefferi Ayalew, Nicolosi Maura, Mudireddy Mythri, Szuber Natasha, Finke Christy M, Lasho Terra L, Hanson Curtis A, Ketterling Rhett P, Pardanani Animesh, Gangat Naseema, Mannarelli Carmela, Fanelli Tiziana, Guglielmelli Paola, Vannucchi Alessandro |
|
Low-burden TP53 mutations in chronic phase of myeloproliferative neoplasms: Association with age, hydroxyurea administration, disease type and JAK2 mutational status.
Leukemia 2017 Jul . Kubesova B, Pavlova S, Malcikova J, Kabathova J, Radova L, Tom N, Tichy B, Plevova K, Kantorova B, Fiedorova K, Slavikova M, Bystry V, Kissova J, Gisslinger B, Gisslinger H, Penka M, Mayer J, Kralovics R, Pospisilova S, Doubek |
|
Morphologic and Molecular Characteristics of De Novo AML With JAK2 V617F Mutation.
Journal of the National Comprehensive Cancer Network : JNCCN 2017 Jun 15 (6): 790-796. Hidalgo-López Juliana E, Kanagal-Shamanna Rashmi, Medeiros L Jeffrey, Estrov Zeev, Yin C Cameron, Verstovsek Srdan, Konoplev Sergej, Jorgensen Jeffrey L, Mohammad Mohammad M, Miranda Roberto N, Zhao Chong, Lee John, Zuo Zhuang, Bueso-Ramos Carlos |
|
Comparison of the Mutational Profiles of Primary Myelofibrosis, Polycythemia Vera, and Essential Thrombocytosis.
American journal of clinical pathology 2017 May 147 (5): 444-452. Song Jinming, Hussaini Mohammad, Zhang Hailing, Shao Haipeng, Qin Dahui, Zhang Xiaohui, Ma Zhenjun, Hussnain Naqvi Syeda Mahrukh, Zhang Ling, Moscinski Lynn |
|
Mutations in TP53 and JAK2 are independent prognostic biomarkers in B-cell precursor acute lymphoblastic leukaemia.
British journal of cancer 2017 May . Forero-Castro Maribel, Robledo Cristina, Benito Rocío, Bodega-Mayor Irene, Rapado Inmaculada, Hernández-Sánchez María, Abáigar María, Maria Hernández-Sánchez Jesús, Quijada-Álamo Miguel, María Sánchez-Pina José, Sala-Valdés Mónica, Araujo-Silva Fernanda, Kohlmann Alexander, Luis Fuster José, Arefi Maryam, de Las Heras Natalia, Riesco Susana, Rodríguez Juan N, Hermosín Lourdes, Ribera Jordi, Camos Guijosa Mireia, Ramírez Manuel, de Heredia Rubio Cristina Díaz, Barragán Eva, Martínez Joaquín, Ribera José M, Fernández-Ruiz Elena, Hernández-Rivas Jesús-Mar |
|
ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.
Genes, chromosomes & cancer 2017 Apr . Zaliova Marketa, Kotrova Michaela, Bresolin Silvia, Stuchly Jan, Stary Jan, Hrusak Ondrej, Te Kronnie Geertruy, Trka Jan, Zuna Jan, Vaskova Marti |
|
JAK2, MPL, and CALR mutations in Chinese Han patients with essential thrombocythemia.
Hematology (Amsterdam, Netherlands) 2017 Apr 22 (3): 145-148. Wang Jing, Zhang Biao, Chen Bing, Zhou Rong-Fu, Zhang Qi-Guo, Li Juan, Yang Yong-Gong, Zhou Min, Shao Xiao-Yan, Xu Yong, Xu Xi-Hui, Ouyang Jian, Xu Jingyan, Ye Qi |
|
Multicolor Flow Cytometry and Multi-Gene Next Generation Sequencing are Complementary and Highly Predictive for Relapse in Acute Myeloid Leukemia Following Allogeneic Transplant.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2017 Mar . Getta Bartlomiej M, Devlin Sean M, Levine Ross L, Arcila Maria E, Mohanty Abhinita S, Zehir Ahmet, Tallman Martin S, Giralt Sergio A, Roshal Mikha |
|
Spectrum of somatic mutations detected by targeted next-generation sequencing and their prognostic significance in adult patients with acute lymphoblastic leukemia.
Journal of hematology & oncology 2017 Feb 10 (1): 61. Feng Juan, Li Yan, Jia Yujiao, Fang Qiuyun, Gong Xiaoyuan, Dong Xiaobao, Ru Kun, Li Qinghua, Zhao Xingli, Liu Kaiqi, Wang Min, Tian Zheng, Jia Yannan, Wang Ying, Lin Dong, Wei Hui, Tang Kejing, Mi Yingchang, Wang Jianxia |
|
[The clinical characteristics, gene mutations and prognosis of chronic neutrophilic leukemia].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2017 Jan 38 (1): 28-32. Cui Y J, Jiang Q, Liu J Q, Li B, Xu Z F, Qin T J, Zhang Y, Cai W Y, Zhang H L, Fang L W, Pan L J, Hu N B, Qu S Q, Xiao Z |
|
Adults with Philadelphia chromosome-like acute lymphoblastic leukemia frequently have IGH-CRLF2 and JAK2 mutations, persistence of minimal residual disease and poor prognosis.
Haematologica 2017 Jan 102 (1): 130-138. Herold Tobias, Schneider Stephanie, Metzeler Klaus H, Neumann Martin, Hartmann Luise, Roberts Kathryn G, Konstandin Nikola P, Greif Philipp A, Bräundl Kathrin, Ksienzyk Bianka, Huk Natalia, Schneider Irene, Zellmeier Evelyn, Jurinovic Vindi, Mansmann Ulrich, Hiddemann Wolfgang, Mullighan Charles G, Bohlander Stefan K, Spiekermann Karsten, Hoelzer Dieter, Brüggemann Monika, Baldus Claudia D, Dreyling Martin, Gökbuget Nico |
|
Impact of genotype on leukaemic transformation in polycythaemia vera and essential thrombocythaemia.
British journal of haematology 2017 09 178 (5): 764-771. Alvarez-Larrán Alberto, Senín Alicia, Fernández-Rodríguez Concepción, Pereira Arturo, Arellano-Rodrigo Eduardo, Gómez Montse, Ferrer-Marin Francisca, Martínez-López Joaquín, Camacho Laura, Colomer Dolors, Angona Anna, Navarro Blanca, Cervantes Francisco, Besses Carlos, Bellosillo Beatriz, Hernández-Boluda Juan Carl |
|
Ph-like acute lymphoblastic leukemia: a high-risk subtype in adults.
Blood 2016 Dec . Jain Nitin, Roberts Kathryn G, Jabbour Elias, Patel Keyur, Eterovic Agda Karina, Chen Ken, Zweidler-McKay Patrick, Lu Xinyan, Fawcett Gloria, Wang Sa A, Konoplev Sergej, Harvey Richard C, Chen I-Ming, Payne-Turner Debbie, Valentine Marcus, Thomas Deborah, Garcia-Manero Guillermo, Ravandi Farhad, Cortes Jorge, Kornblau Steven, O'Brien Susan, Pierce Sherry, Jorgensen Jeffrey, Shaw Kenna R Mills, Willman Cheryl L, Mullighan Charles G, Kantarjian Hagop, Konopleva Mari |
|
Detection of CALR Mutation in Clonal and Nonclonal Hematologic Diseases Using Fragment Analysis and Next-Generation Sequencing.
American journal of clinical pathology 2016 Oct 146 (4): 448-55. Gardner Juli-Anne, Peterson Jason D, Turner Scott A, Soares Barbara L, Lancor Courtney R, Dos Santos Luciana L, Kaur Prabhjot, Ornstein Deborah L, Tsongalis Gregory J, de Abreu Francine |
|
ASXL1 and JAK2V617F gene mutation screening in Iranian patients with chronic myeloid leukemia.
Asia-Pacific journal of clinical oncology 2016 Sep . Valikhani Amir, Poopak Behzad, Ferdowsi Shirin, Azizi Tabesh Ghasem, Ghaffari Seyed H, Saraf Kazeruoni Ehsan, Rezaei Negar, Farshchi Alireza, Amirizadeh Nas |
|
Prognostic Significance of P2RY8-CRLF2 and CRLF2 Overexpression May Vary Across Risk Subgroups of Childhood B-cell Acute Lymphoblastic Leukemia.
Genes, chromosomes & cancer 2016 Sep . Dou Hu, Chen Xi, Huang Yi, Su Yongchun, Lu Ling, Yu Jie, Yin Yibing, Bao Limi |
|
Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.
Annals of hematology 2016 Sep . Kourie Hampig Raphael, Ameye Lieveke, Paesmans Marianne, Bron Dominiq |
|
Simultaneous screening for JAK2 and calreticulin gene mutations in myeloproliferative neoplasms with high resolution melting.
Clinica chimica acta; international journal of clinical chemistry 2016 Sep 462 166-173. Matsumoto Nariyoshi, Mori Sayaka, Hasegawa Hiroo, Sasaki Daisuke, Mori Hayato, Tsuruda Kazuto, Imanishi Daisuke, Imaizumi Yoshitaka, Hata Tomoko, Kaku Norihito, Kosai Kousuke, Uno Naoki, Miyazaki Yasushi, Yanagihara Katsuno |
|
Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia.
British journal of haematology 2016 Aug . Bhatnagar Bhavana, Eisfeld Ann-Kathrin, Nicolet Deedra, Mrózek Krzysztof, Blachly James S, Orwick Shelley, Lucas David M, Kohlschmidt Jessica, Blum William, Kolitz Jonathan E, Stone Richard M, Bloomfield Clara D, Byrd John |
|
Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.
Annals of hematology 2016 Jul . Pei Yu-Qing, Wu Yue, Wang Fei, Cui W |
|
Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Leukemia & lymphoma 2016 Jul 1-8. Balassa Katalin, Krahling Tunde, Remenyi Peter, Batai Arpad, Bors Andras, Kiss Katalin Piroska, Torbagyi Eva, Gopcsa Laszlo, Lengyel Lilla, Barta Aniko, Varga Gergely, Tordai Attila, Masszi Tamas, Andrikovics Hajnal |
|
The expression of Death Inducer-Obliterator (DIDO) variants in Myeloproliferative Neoplasms.
Blood cells, molecules & diseases 2016 Jul 59 25-30. Berzoti-Coelho Maria Gabriela, Ferreira Aline Fernanda, de Souza Nunes Natalia, Pinto Mariana Tomazini, Júnior Maurício Cristiano Rocha, Simões Belinda Pinto, Martínez-A Carlos, Souto Elizabeth Xisto, Panepucci Rodrigo Alexandre, Covas Dimas Tadeu, Kashima Simone, Castro Fabíola Att |
|
Disease characteristics and outcomes in younger adults with primary and secondary myelofibrosis.
British journal of haematology 2016 Jun . Beauverd Yan, Alimam Samah, McLornan Donal P, Radia Deepti H, Harrison Claire |
|
Mutation profiling of 19 candidate genes in acute myeloid leukemia suggests significance of DNMT3A mutations.
Oncotarget 2016 Jun . Shin Sang-Yong, Lee Seung-Tae, Kim Hee-Jin, Cho Eun Hae, Kim Jong-Won, Park Silvia, Jung Chul Won, Kim Sun-H |
|
Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia.
American journal of hematology 2016 May 91 (5): 503-6. Elala Yoseph C, Lasho Terra L, Gangat Naseema, Finke Christy, Barraco Daniela, Haider Mahnur, Abou Hussein Ahmed K, Hanson Curtis A, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayal |
|
The 5q deletion size in myeloid malignancies is correlated to additional chromosomal aberrations and to TP53 mutations.
Genes, chromosomes & cancer 2016 May . Stengel Anna, Kern Wolfgang, Haferlach Torsten, Meggendorfer Manja, Haferlach Claud |
|
Association of TNF polymorphisms with JAK2 (V617F) myeloproliferative neoplasms in Brazilian patients.
Blood cells, molecules & diseases 2016 Mar 57 54-7. Macedo Luciana Conci, de Cesare Quintero Fernanda, Pagliari-E-Silva Sara, Pagnano Katia Borgia Barbosa, Rodrigues Camila, de Alencar Josiane Bazzo, Sell Ana Maria, Visentainer Jeane Eliete Lagui |
|
Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.
Clinical lymphoma, myeloma & leukemia 2016 Feb . Kourie Hampig Raphael, Ameye Lieveke, Paesmans Marianne, Bron Dominiq |
|
The Polymorphisms in LNK Gene Correlated to the Clinical Type of Myeloproliferative Neoplasms.
PloS one 2016 11 (4): e0154183. Chen Yan, Fang Fang, Hu Yang, Liu Qian, Bu Dingfang, Tan Mei, Wu Liusong, Zhu Pi |
|
Co-occurrence of myeloproliferative neoplasms and solid tumors is attributed to a synergism between cytoreductive therapy and the common TERT polymorphism rs2736100.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Oct . Krahling Tunde, Balassa Katalin, Kiss Katalin P, Bors Andras, Batai Arpad, Halm Gabriella, Egyed Miklos, Fekete Sandor, Remenyi Peter, Masszi Tamas, Tordai Attila, Andrikovics Hajnal |
|
Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations.
Haematologica 2015 Jul 100 (7): 893-7. Al Assaf Carla, Van Obbergh Florence, Billiet Johan, Lierman Els, Devos Timothy, Graux Carlos, Hervent Anne-Sophie, Emmerechts Jan, Tousseyn Thomas, De Paepe Pascale, Papadopoulos Petros, Michaux Lucienne, Vandenberghe Pet |
|
JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis.
Journal of Korean medical science 2015 Jul 30 (7): 882-8. Kim Bo Hyun, Cho Young-Uk, Bae Mi-Hyun, Jang Seongsoo, Seo Eul-Ju, Chi Hyun-Sook, Choi Yunsuk, Kim Dae-Young, Lee Jung-Hee, Lee Je-Hwan, Lee Kyoo-Hyung, Park Young-Mi, Lee Jong-Keuk, Park Chan-Jeou |
|
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.
Leukemia 2015 Jun 29 (6): 1344-9. Palandri F, Latagliata R, Polverelli N, Tieghi A, Crugnola M, Martino B, Perricone M, Breccia M, Ottaviani E, Testoni N, Merli F, Aversa F, Alimena G, Cavo M, Martinelli G, Catani L, Baccarani M, Vianelli |
|
Cooperative genetic changes in pediatric B-cell precursor acute lymphoblastic leukemia with deletions or mutations of IKZF1.
Genes, chromosomes & cancer 2015 May 54 (5): 315-25. Olsson Linda, Albitar Ferras, Castor Anders, Behrendtz Mikael, Biloglav Andrea, Paulsson Kajsa, Johansson Bert |
|
Next-generation sequencing of acute myeloid leukemia identifies the significance of TP53, U2AF1, ASXL1, and TET2 mutations.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2015 May 28 (5): 706-14. Ohgami Robert S, Ma Lisa, Merker Jason D, Gotlib Jason R, Schrijver Iris, Zehnder James L, Arber Daniel |
|
Profound parental bias associated with chromosome 14 acquired uniparental disomy indicates targeting of an imprinted locus.
Leukemia 2015 May . Chase A, Leung W, Tapper W, Jones A V, Knoops L, Rasi C, Forsberg L A, Guglielmelli P, Zoi K, Hall V, Chiecchio L, Eder-Azanza L, Bryant C, Lannfelt L, Docherty L, White H E, Score J, Mackay D J G, Vannucchi A M, Dumanski J P, Cross N C |
|
Calreticulin exon 9 mutations in myeloproliferative neoplasms.
Annals of laboratory medicine 2015 Jan 35 (1): 22-7. Ha Jung-Sook, Kim Yu-Kyu |
|
CALR mutation screening in pediatric primary myelofibrosis.
Pediatric blood & cancer 2014 Dec 61 (12): 2256-62. An Wenbin, Wan Yang, Guo Ye, Chen Xiaojuan, Ren Yuanyuan, Zhang Jingliao, Chang Lixian, Wei Wei, Zhang Peihong, Zhu Xiaof |
|
JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms.
Clinical lymphoma, myeloma & leukemia 2014 Dec 14 (6): 525-33. Payzin Kadriye Bahriye, Savasoglu Kaan, Alacacioglu Inci, Ozdemirkiran Fusun, Mutlu Belgin Berber, Bener Sadi, Calli Aylin Orgen, Kucukzeybek Betul Bolat, Aksun Sali |
|
Leukemic transformation in essential thrombocythemia.
Future oncology (London, England) 2014 Dec 10 (16): 2593-602. Bhatt Vijaya R |
|
The detection of SRSF2 mutations in routinely processed bone marrow biopsies is useful in the diagnosis of chronic myelomonocytic leukemia.
Human pathology 2014 Dec 45 (12): 2471-9. Federmann Birgit, Abele Manuel, Rosero Cuesta David Santiago, Vogel Wichard, Boiocchi Leonardo, Kanz Lothar, Quintanilla-Martinez Leticia, Orazi Attilio, Bonzheim Irina, Fend Fal |
|
Gene alterations involving the CRLF2-JAK pathway and recurrent gene deletions in Down syndrome-associated acute lymphoblastic leukemia in Japan.
Genes, chromosomes & cancer 2014 Nov 53 (11): 902-10. Hanada Isamu, Terui Kiminori, Ikeda Fumika, Toki Tsutomu, Kanezaki Rika, Sato Tomohiko, Kamio Takuya, Kudo Ko, Sasaki Shinya, Takahashi Yoshihiro, Hayashi Yasuhide, Inukai Takeshi, Kojima Seiji, Koike Kenichi, Kosaka Yoshiyuki, Kobayashi Masao, Imaizumi Masue, Mitsui Tetsuo, Hori Hiroki, Hara Junichi, Horibe Keizo, Nagai Jun-ichi, Goto Hiroaki, Ito Etsu |
|
Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis.
Blood 2014 Oct 124 (16): 2507-13; quiz 2615. Tefferi Ayalew, Guglielmelli Paola, Larson Dirk R, Finke Christy, Wassie Emnet A, Pieri Lisa, Gangat Naseema, Fjerza Rajmonda, Belachew Alem A, Lasho Terra L, Ketterling Rhett P, Hanson Curtis A, Rambaldi Alessandro, Finazzi Guido, Thiele Juergen, Barbui Tiziano, Pardanani Animesh, Vannucchi Alessandro |
|
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.
Blood 2014 Aug 124 (7): 1062-9. Rumi Elisa, Pietra Daniela, Pascutto Cristiana, Guglielmelli Paola, Martínez-Trillos Alejandra, Casetti Ilaria, Colomer Dolors, Pieri Lisa, Pratcorona Marta, Rotunno Giada, Sant'Antonio Emanuela, Bellini Marta, Cavalloni Chiara, Mannarelli Carmela, Milanesi Chiara, Boveri Emanuela, Ferretti Virginia, Astori Cesare, Rosti Vittorio, Cervantes Francisco, Barosi Giovanni, Vannucchi Alessandro M, Cazzola Mario, |
|
JAK2 V617F detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms: A report of two cases.
Oncology letters 2014 Aug 8 (2): 841-844. Yang Yi-Ning, Qin You-Wen, Wang Ch |
|
Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients.
American journal of hematology 2014 Aug 89 (8): E121-4. Tefferi Ayalew, Wassie Emnet A, Guglielmelli Paola, Gangat Naseema, Belachew Alem A, Lasho Terra L, Finke Christy, Ketterling Rhett P, Hanson Curtis A, Pardanani Animesh, Wolanskyj Alexandra P, Maffioli Margherita, Casalone Rosario, Pacilli Annalisa, Vannucchi Alessandro M, Passamonti Frances |
|
High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome.
Leukemia 2014 Jul 28 (7): 1449-58. Krauth M-T, Eder C, Alpermann T, Bacher U, Nadarajah N, Kern W, Haferlach C, Haferlach T, Schnittger |
|
Bone marrow fibrosis in patients with primary myelodysplastic syndromes has prognostic value using current therapies and new risk stratification systems.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 May 27 (5): 681-9. Fu Bin, Jaso Jesse M, Sargent Rachel L, Goswami Maitrayee, Verstovsek Srdan, Medeiros L Jeffrey, Wang Sa |
|
Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.
Blood 2014 Apr 123 (14): 2220-8. Lundberg Pontus, Karow Axel, Nienhold Ronny, Looser Renate, Hao-Shen Hui, Nissen Ina, Girsberger Sabine, Lehmann Thomas, Passweg Jakob, Stern Martin, Beisel Christian, Kralovics Robert, Skoda Radek |
|
Frequency of JAK2 V617F mutation in patients with Philadelphia positive Chronic Myeloid Leukemia in Pakistan.
Pakistan journal of medical sciences 2014 Jan 30 (1): 185-8. Tabassum Najia, Saboor Mohammed, Ghani Rubina, Moinuddin Moinudd |
|
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome.
Blood cancer journal 2014 4 e177. Chen T-C, Hou H-A, Chou W-C, Tang J-L, Kuo Y-Y, Chen C-Y, Tseng M-H, Huang C-F, Lai Y-J, Chiang Y-C, Lee F-Y, Liu M-C, Liu C-W, Liu C-Y, Yao M, Huang S-Y, Ko B-S, Hsu S-C, Wu S-J, Tsay W, Chen Y-C, Tien H |
|
Frequent cases of RAS-mutated Down syndrome acute lymphoblastic leukaemia lack JAK2 mutations.
Nature communications 2014 5 4654. Nikolaev Sergey I, Garieri Marco, Santoni Federico, Falconnet Emilie, Ribaux Pascale, Guipponi Michel, Murray Aoife, Groet Jürgen, Giarin Emanuela, Basso Giuseppe, Nizetic Dean, Antonarakis Stylianos |
|
Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
The New England journal of medicine 2013 Dec 369 (25): 2391-405. Nangalia J, Massie C E, Baxter E J, Nice F L, Gundem G, Wedge D C, Avezov E, Li J, Kollmann K, Kent D G, Aziz A, Godfrey A L, Hinton J, Martincorena I, Van Loo P, Jones A V, Guglielmelli P, Tarpey P, Harding H P, Fitzpatrick J D, Goudie C T, Ortmann C A, Loughran S J, Raine K, Jones D R, Butler A P, Teague J W, O'Meara S, McLaren S, Bianchi M, Silber Y, Dimitropoulou D, Bloxham D, Mudie L, Maddison M, Robinson B, Keohane C, Maclean C, Hill K, Orchard K, Tauro S, Du M-Q, Greaves M, Bowen D, Huntly B J P, Harrison C N, Cross N C P, Ron D, Vannucchi A M, Papaemmanuil E, Campbell P J, Green A |
|
Mutations and prognosis in primary myelofibrosis.
Leukemia 2013 Sep 27 (9): 1861-9. Vannucchi A M, Lasho T L, Guglielmelli P, Biamonte F, Pardanani A, Pereira A, Finke C, Score J, Gangat N, Mannarelli C, Ketterling R P, Rotunno G, Knudson R A, Susini M C, Laborde R R, Spolverini A, Pancrazzi A, Pieri L, Manfredini R, Tagliafico E, Zini R, Jones A, Zoi K, Reiter A, Duncombe A, Pietra D, Rumi E, Cervantes F, Barosi G, Cazzola M, Cross N C P, Tefferi |
|
SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations.
Leukemia 2013 Sep 27 (9): 1852-60. Meggendorfer M, Bacher U, Alpermann T, Haferlach C, Kern W, Gambacorti-Passerini C, Haferlach T, Schnittger |
|
Prognostic score including gene mutations in chronic myelomonocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Jul 31 (19): 2428-36. Itzykson Raphaël, Kosmider Olivier, Renneville Aline, Gelsi-Boyer Véronique, Meggendorfer Manja, Morabito Margot, Berthon Céline, Adès Lionel, Fenaux Pierre, Beyne-Rauzy Odile, Vey Norbert, Braun Thorsten, Haferlach Torsten, Dreyfus François, Cross Nicholas C P, Preudhomme Claude, Bernard Olivier A, Fontenay Michaela, Vainchenker William, Schnittger Susanne, Birnbaum Daniel, Droin Nathalie, Solary Er |
|
IKZF1 deletion is associated with a poor outcome in pediatric B-cell precursor acute lymphoblastic leukemia in Japan.
Cancer medicine 2013 Jun 2 (3): 412-9. Asai Daisuke, Imamura Toshihiko, Suenobu So-ichi, Saito Akiko, Hasegawa Daiichiro, Deguchi Takao, Hashii Yoshiko, Matsumoto Kimikazu, Kawasaki Hirohide, Hori Hiroki, Iguchi Akihiro, Kosaka Yoshiyuki, Kato Koji, Horibe Keizo, Yumura-Yagi Keiko, Hara Junichi, Oda Megumi, |
|
[Clinical significance of common leukemia gene mutations in patients with acute promyelocytic leukemia].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2013 Jan 21 (1): 1. Yin J, Sun AN, Tian XP, Tian H, Wang RX, Yang Z, Wang XL, Wu DP, Qiu HY, Pan JL, Cen JN, Liang JY, Chen SN |
|
Secondary genetic lesions in acute myeloid leukemia with inv(16) or t(16;16): a study of the German-Austrian AML Study Group (AMLSG).
Blood 2013 Jan 121 (1): 170-7. Paschka Peter, Du Juan, Schlenk Richard F, Gaidzik Verena I, Bullinger Lars, Corbacioglu Andrea, Späth Daniela, Kayser Sabine, Schlegelberger Brigitte, Krauter Jürgen, Ganser Arnold, Köhne Claus-Henning, Held Gerhard, von Lilienfeld-Toal Marie, Kirchen Heinz, Rummel Mathias, Götze Katharina, Horst Heinz-August, Ringhoffer Mark, Lübbert Michael, Wattad Mohammed, Salih Helmut R, Kündgen Andrea, Döhner Hartmut, Döhner Konstan |
|
The JAK2V617F tyrosine kinase mutation has no impact on overall survival and the risk of leukemic transformation in myelofibrosis.
Medical oncology (Northwood, London, England) 2012 Dec 29 (4): 2379-84. Helbig Grzegorz, Wieczorkiewicz Agata, Wo?niczka Krzysztof, Wi?niewska-Pi?ty Katarzyna, Rusek Anna, Kyrcz-Krzemie? S?awomi |
|
Use of CBL exon 8 and 9 mutations in diagnosis of myeloproliferative neoplasms and myelodysplastic/myeloproliferative disorders: an analysis of 636 cases.
Haematologica 2012 Dec 97 (12): 1890-4. Schnittger Susanne, Bacher Ulrike, Alpermann Tamara, Reiter Andreas, Ulke Madlen, Dicker Frank, Eder Christiane, Kohlmann Alexander, Grossmann Vera, Kowarsch Andreas, Kern Wolfgang, Haferlach Claudia, Haferlach Torst |
|
IDH2 mutations are frequent in Chinese patients with acute myeloid leukemia and associated with NPM1 mutations and FAB-M2 subtype.
International journal of laboratory hematology 2012 Oct 34 (5): 502-9. Chao H-Y, Jia Z-X, Chen T, Lu X-Z, Cen L, Xiao R, Jiang N-K, Ying J-H, Zhou M, Zhang |
|
Molecular analyses of 15,542 patients with suspected BCR-ABL1-negative myeloproliferative disorders allow to develop a stepwise diagnostic workflow.
Haematologica 2012 Oct 97 (10): 1582-5. Schnittger Susanne, Bacher Ulrike, Eder Christiane, Dicker Frank, Alpermann Tamara, Grossmann Vera, Kohlmann Alexander, Kern Wolfgang, Haferlach Claudia, Haferlach Torst |
|
Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations.
Leukemia 2012 Oct 26 (10): 2204-11. Buitenkamp T D, Pieters R, Gallimore N E, van der Veer A, Meijerink J P P, Beverloo H B, Zimmermann M, de Haas V, Richards S M, Vora A J, Mitchell C D, Russell L J, Schwab C, Harrison C J, Moorman A V, van den Heuvel-Eibrink M M, den Boer M L, Zwaan C |
|
SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).
Blood 2012 Oct 120 (15): 3080-8. Meggendorfer Manja, Roller Andreas, Haferlach Torsten, Eder Christiane, Dicker Frank, Grossmann Vera, Kohlmann Alexander, Alpermann Tamara, Yoshida Kenichi, Ogawa Seishi, Koeffler H Phillip, Kern Wolfgang, Haferlach Claudia, Schnittger Susan |
|
Epigenetic dysregulation of secreted frizzled-related proteins in myeloproliferative neoplasms complements the JAK2V617F-mutation.
Clinical epigenetics 2012 Aug 4 (1): 1. Bennemann K, Galm O, Wilop S, Schubert C, Bruemmendorf TH, Jost E |
|
Mutation analysis of ASXL1, CBL, DNMT3A, IDH1, IDH2, JAK2, MPL, NF1, SF3B1, SUZ12, and TET2 in myeloproliferative neoplasms.
Genes, chromosomes & cancer 2012 Aug 51 (8): 743-55. Brecqueville Mandy, Rey Jérôme, Bertucci François, Coppin Emilie, Finetti Pascal, Carbuccia Nadine, Cervera Nathalie, Gelsi-Boyer Véronique, Arnoulet Christine, Gisserot Olivier, Verrot Denis, Slama Borhane, Vey Norbert, Mozziconacci Marie-Joelle, Birnbaum Daniel, Murati An |
|
Investigation and analysis of single nucleotide polymorphisms in Janus kinase/signal transducer and activator of transcription genes with leukemia.
Leukemia & lymphoma 2012 Jun 53 (6): 1216-21. Zhong Yuejiao, Wu Jianzhong, Chen Baoan, Ma Rong, Cao Haixia, Wang Zhuo, Cheng Lu, Ding Jiahua, Feng Jife |
|
Genetic analysis of patients with leukemic transformation of myeloproliferative neoplasms shows recurrent SRSF2 mutations that are associated with adverse outcome.
Blood 2012 May 119 (19): 4480-5. Zhang Su-Jiang, Rampal Raajit, Manshouri Taghi, Patel Jay, Mensah Nana, Kayserian Andrew, Hricik Todd, Heguy Adriana, Hedvat Cyrus, Gönen Mithat, Kantarjian Hagop, Levine Ross L, Abdel-Wahab Omar, Verstovsek Srd |
|
Somatic STAT3 mutations in large granular lymphocytic leukemia.
The New England journal of medicine 2012 May 366 (20): 1905-13. Koskela Hanna L M, Eldfors Samuli, Ellonen Pekka, van Adrichem Arjan J, Kuusanmäki Heikki, Andersson Emma I, Lagström Sonja, Clemente Michael J, Olson Thomas, Jalkanen Sari E, Majumder Muntasir Mamun, Almusa Henrikki, Edgren Henrik, Lepistö Maija, Mattila Pirkko, Guinta Kathryn, Koistinen Pirjo, Kuittinen Taru, Penttinen Kati, Parsons Alun, Knowles Jonathan, Saarela Janna, Wennerberg Krister, Kallioniemi Olli, Porkka Kimmo, Loughran Thomas P, Heckman Caroline A, Maciejewski Jaroslaw P, Mustjoki Sa |
|
IDH mutations in primary myelofibrosis predict leukemic transformation and shortened survival: clinical evidence for leukemogenic collaboration with JAK2V617F.
Leukemia 2012 Mar 26 (3): 475-80. Tefferi A, Jimma T, Sulai N H, Lasho T L, Finke C M, Knudson R A, McClure R F, Pardanani |
|
Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome.
Blood 2012 Mar 119 (10): 2219-27. Giona Fiorina, Teofili Luciana, Moleti Maria Luisa, Martini Maurizio, Palumbo Giovanna, Amendola Angela, Mazzucconi Maria Gabriella, Testi Anna Maria, Pignoloni Patrizia, Orlando Sonia Maria, Capodimonti Sara, Nanni Mauro, Leone Giuseppe, Larocca Luigi Maria, Foà Rob |
|
Rapid identification of heterozygous or homozygous JAK2(V617F) mutations in myeloproliferative neoplasms using melting curve analysis.
Journal of the Formosan Medical Association = Taiwan yi zhi 2012 Jan 111 (1): 34-40. Ho Ching-Liang, Wu Yi-Ying, Hung Hsiu-Man, Chang Ping-Ying, Kao Wei-You, Chen Yeu-Chin, Chao Tsu- |
|
Primary myelofibrosis with or without mutant MPL: comparison of survival and clinical features involving 603 patients.
Leukemia 2011 Dec 25 (12): 1834-9. Pardanani A, Guglielmelli P, Lasho T L, Pancrazzi A, Finke C M, Vannucchi A M, Tefferi |
|
The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia.
Haematologica 2011 Nov 96 (11): 1613-8. Nahajevszky Sarolta, Andrikovics Hajnalka, Batai Arpad, Adam Emma, Bors Andras, Csomor Judit, Gopcsa Laszlo, Koszarska Magdalena, Kozma Andras, Lovas Nora, Lueff Sandor, Matrai Zoltan, Meggyesi Nora, Sinko Janos, Sipos Andrea, Varkonyi Andrea, Fekete Sandor, Tordai Attila, Masszi Tam |
|
[Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2011 Oct 32 (10): 679-83. Qiao Man, Li Wei-yang, Sun Ai-ning, Chen Su-ning, Liang Jian-ying, Ding Zi-xuan, Feng Yu-feng, Wu De-p |
|
Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes.
Haematologica 2011 Oct 96 (10): 1462-9. Stein Brady L, Williams Donna M, O'Keefe Christine, Rogers Ophelia, Ingersoll Roxann G, Spivak Jerry L, Verma Amit, Maciejewski Jarek P, McDevitt Michael A, Moliterno Alison |
|
Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood 2011 Sep 118 (11): 3080-7. Zhang Jinghui, Mullighan Charles G, Harvey Richard C, Wu Gang, Chen Xiang, Edmonson Michael, Buetow Kenneth H, Carroll William L, Chen I-Ming, Devidas Meenakshi, Gerhard Daniela S, Loh Mignon L, Reaman Gregory H, Relling Mary V, Camitta Bruce M, Bowman W Paul, Smith Malcolm A, Willman Cheryl L, Downing James R, Hunger Stephen |
|
JAK2-V617F mutation in Moroccan patients with myeloproliferative disorders: contribution, diagnosis and therapeutic prospects.
Pathologie-biologie 2011 Aug 59 (4): e89-92. Benmoussa A, Dehbi H, Fehri S, Quessar A, Nadifi |
|
JAK2V617F mutation in chronic myeloid leukemia predicts early disease progression.
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 2011 Aug 21 (8): 472-5. Pahore Zaen-Al-Abideen, Shamsi Tahir S, Taj Mehwesh, Farzana Tasneem, Ansari Saqib H, Nadeem Muhammad, Ahmad Masood, Naz Ars |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 18, 2020
- Content source: